Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
Early career researcher Marvin Langston, PhD, MPH, studies potential links between infections, inflammation, and cancer as well as racial/ethnic and sexual minority health disparities.
Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.
A new prostate cancer risk calculator developed by Kaiser Permanente Northern California researchers may help men going through prostate cancer screening decide whether to have a prostate biopsy.
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.
Patients reported positive outcomes with use of an HIV prevention medication dosed only as needed, instead of the more common daily dosing, Kaiser Permanente researchers reported.
A Kaiser Permanente randomized controlled trial comparing an in-person diabetes prevention program with an online version found both helped San Francisco City and County employees at risk for developing diabetes to lose weight.
Patients who followed more medical advice after a heart attack were more likely to survive years later, and their prospects improved with every additional recommendation they followed, according to new research from Kaiser Permanente published in the Journal of the American Heart Association.
“This research brings a large amount of data to bear on a basic question, and it gives such a clear answer,” said lead author Alexander C. Flint, MD, PhD, Kaiser Permanente stroke specialist and adjunct researcher with the Division of Research. “Every way you slice the data, the systolic and diastolic pressures are both important.”
Coinciding with Colon Cancer Awareness Month (March), Kaiser Permanente Northern California received the National Colorectal Cancer Roundtable’s prestigious “80% by 2018” National Achievement Award, in recognition of screening rates over 83 percent for colorectal cancer.